Stylus Medicine is a Cambridge, Massachusetts biotechnology company developing in vivo genetic medicines built on engineered recombinases. Its platform aims to generate precise, durable CAR-T cells directly inside the body using cell-targeted lipid nanoparticle delivery to immune cells, with therapeutic programs spanning oncology, autoimmune… - View it on GitHub